GC Wealth Management RIA, LLC

Position in JNJ — Johnson & Johnson

CIK 2011169 Cambridge, MA

Position in JNJ

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$4,767,778

-$510,659 QoQ

Shares Held

18,773

-13.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#1,655

of 4,676 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GC Wealth Management RIA, LLC holds $51,496,913 across 12 Drug Manufacturers - General names. JNJ ranks #4 (9.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	18,328	$21,983,154
2	ABBV	AbbVie Inc.	37,102	$9,336,347
3	MRK	Merck & Co., Inc.	39,089	$5,022,936
4	JNJ	Johnson & Johnson This page	18,773	$4,767,778
5	AZN	Astrazeneca PLC	18,143	$3,440,275
6	AMGN	Amgen Inc	6,073	$2,199,154
7	NVO	Novo Nordisk A S	39,641	$1,900,389
8	NVS	Novartis AG	6,349	$995,015

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,767,778	18,773	-13.1%	Shares	Sole	2026-07-16
2026-03-31	$5,278,437	21,594	-6.9%	Shares	Sole	2026-05-14
2025-12-31	$4,802,274	23,205	-53.8%	Shares	Sole	2026-01-30
2025-09-30	$9,318,838	50,258	+121.1%	Shares	Sole	2025-11-13
2025-06-30	$3,472,465	22,733	+149.9%	Shares	Sole	2025-07-17
2025-03-31	$1,508,812	9,098	+0.3%	Shares	Sole	2025-05-12
2024-12-31	$1,311,558	9,069	+4.1%	Shares	Sole	2025-02-07
2024-09-30	$1,412,352	8,715	+0.5%	Shares	Sole	2024-11-04
2024-06-30	$1,267,207	8,670	-45.0%	Shares	Sole	2024-07-31
2024-03-31	$2,494,972	15,772	+25.6%	Shares	Sole	2024-05-10
2023-12-31	$1,968,184	12,557	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.